Arai, Alshera M.
HRN: 24-48-57 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/08/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
02/08/2025
02/15/2025
IV DRIP
400 Mg
Q6H
Carbunculosis, AGE
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes